glp 1 for mash GLP-1s are gaining traction in MASLD and MASH—but where do they fit among today's treatment options? Explore the latest evidence and what it means specialty pharmacy: https://t.co/DStFc9vyv3 #GLP1 #MASLD #MASH #Pharmacy MASH therapy enters a more

Neuroprotective effect of antidiabetic agents Metformin and neuroprotection Considering the link between diabetes and the increased risks of AD and PD, researchers have investigated the possible neuroprotective effect of antidiabetic agents

GLP-1 stimulates glucose-dependent insulin secretion by pancreatic cells, inhibits glucagon secretion, and regulates postprandial glycemia, as well as cytoprotective and anti-inflammatory activities on cells [16,17,18]

At week 72, primary endpoints showed 62.9% of people treated with 2.4 mg semaglutide achieved resolution of steatohepatitis with no worsening of liver fibrosis compared to 34.1% on placebo

Did you know